Expression of B7–1, B7–2, and Interleukin–12 in Anti–Fas Antibody–Induced Pulmonary Fibrosis in Mice
- 1 June 1999
- journal article
- research article
- Published by S. Karger AG in International Archives of Allergy and Immunology
- Vol. 119 (2) , 112-119
- https://doi.org/10.1159/000024185
Abstract
Background: We have previously reported that the inhalation of anti–Fas antibody induced pulmonary fibrosis in mice. To induce an effective immune response, antigen–presenting cells have to not only present antigenic peptide with MHC molecules to T lymphocytes, but also express B7 costimulating molecules. The purpose of this study is to investigate whether B7 family costimulating molecules and interleukin–12 (IL–12), which primarily promote cellular immunity, are associated with anti–Fas antibody–induced pulmonary fibrosis. Methods: We examined the expression of B7–1, B7–2, and IL–12 using the revese transcription–polymerase chain reaction (RT–PCR), RT–in situ PCR, and immunohistochemistry. Results: We observed the upregulation of B7–1, B7–2, and IL–12 p40 mRNA after anti–Fas antibody inhalation. B7–2 and IL–12 p40 mRNA appeared to be expressed in mononuclear cells, while B7–1 mRNA and protein were expressed in bronchiolar epithelial cells as well as macrophages. Conclusion: These findings indicate that the T–cell–mediated immune response in this model involved the upregulation of B7–1, B7–2, and IL–12, and that the aberrant expression of B7–1 in bronchiolar epithelial cells may induce autoreactive T cell proliferation against themselves.Keywords
This publication has 9 references indexed in Scilit:
- Caspase 1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligandNature Medicine, 1998
- Expression of B7–1, B7–2, and Interleukin 12 in Bleomycin–Induced Pneumopathy in MiceInternational Archives of Allergy and Immunology, 1998
- New perspectives of C1328-137-mediated T cell costimulationImmunity, 1995
- B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapyCell, 1995
- Expression of the B7/BB1 Activation Antigen and its Ligand CD28 in T-Cell-Mediated Skin DiseasesJournal of Investigative Dermatology, 1994
- Absence of B7-dependent responses in CD28-deficient miceImmunity, 1994
- B70 antigen is a second ligand for CTLA-4 and CD28Nature, 1993
- The Role of the CD28 Receptor During T Cell Responses To AntigensAnnual Review of Immunology, 1993
- Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.The Journal of Experimental Medicine, 1993